title: Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
authors: Klinik für Transplantationschirurgie, Georg-August-Universität, Göttingen, Germany.
authors: F
authors: F
authors: Braun
authors: T
authors: T
authors: Lorf
authors: E
authors: E
authors: Schütz
authors: R
authors: R
authors: Canelo
authors: U
authors: U
authors: Hanack
authors: K
authors: K
authors: Döpkens
authors: B
authors: B
authors: Sattler
authors: C
authors: C
authors: Grupp
authors: B
authors: B
authors: Ringe
mesh_terms: D000328:Adult; D000368:Aged; D002102:Cadaver; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology* / Q000276:immunology; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use*; D014019:Tissue Donors
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus